Loading...
StocksRunner logo
 
 
Aemetis
6.63
+10.13%
 
AMTX Aemetis
Last Price
Change
6.63
 
+10.13%
 
 
 

 
Sentiment
 
 

2.06

2.75

4.7

5.53

 
 
1m
3m
6m
1y
 

Summary

  Login to display Aemetis (AMTX) recommendation from the last 90 days from financial news and social media.
 

Strengths

Rewards

 Upgraded on attractively valued

 

Risk Analysis

Risk Analysis

 Analysts lowered price target

Risk Analysis

 Earnings are forecast to decrease

 

Technical Indicators

Technical Indicators

 Up While Market is Down

Technical Indicators

 RSI is overbought

 
 

Risk Level

 
StocksRunner
 

Aemetis (AMTX) has High Risk Level

Click here to check what is your level of risk

 

Analysts Opinion

Click on the category for more information
 
 

Earnings

×
 

Earnings

2.00
 

StocksRunner

 Reported a weak earnings

 
 

Rating

×
 

Rating

5.00
 

StocksRunner

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

3.00
 
 

Activity

×
 

Activity

3.71
 
 

Future

×
 

Future

1.00
 

StocksRunner

 Analysts lowered price target

StocksRunner

 Earnings are forecast to decrease

 
 

Analysts Opinion

Analysts opinion is negative but has improved from the past 3 months

 

Street Consensus

Buy
Opinion
Trend
Score
Potential
Score
 
54%
100%
0%
0%
 
On Track
On Track
On Track
 

Street Opinion 

Street view is bullish but have mixed views on the near-term outlook

 
Events Rating
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
Positive vs Negative
 
54%
38%
Positive
Negative
7 out of 13
events present
5 out of 13
events present
 

 
Events Calendar
Click for more information
 
May
S
M
T
W
T
F
S
June
S
M
T
W
T
F
S
 
Highlights
Last
Modify
Closing
Price
%
Change

 
Investors Selling
This Week
5.78
-16.83%
 
Weak Earnings
2 Month Ago
1.75
-19.35%
 
Buy Rating
2 Month Ago
2.22
+2.55%
 
Price Target Lowered
2 Month Ago
2.23
+3.24%
 
Top Headlines

aemetis unusual options activity for june 07. someone with a lot of money to spend has taken a bearish stance on ). and retail traders should know. we noticed this today when the big position showed up on publicly available options history that we track

Wed Jun 7, 2023

Activity
Activity
Momentum
Potential

aemetis rng production plant receives epa approval for d3 rin generation.

Thu May 18, 2023

Activity

aemetis (amtx) reports q1 loss lags revenue estimates. aemetis (amtx) came out with a quarterly loss of $0.73 per share versus the zacks consensus estimate of a loss of $0.29. this compares to loss of $0.54 per share a year ago. these

Thu May 4, 2023

Earnings

earnings preview: aemetis. ) is set to give its latest quarterly earnings report on thursday 2023-05-04. here'.s what investors need to know before the announcement. analysts estimate that aemetis will report an aemetis s will hope to hear the comp

Wed May 3, 2023

Activity

stifel maintains aemetis (amtx) buy recommendation. fintel reports that on april 27 2023 stifel maintained coverage of aemetis (nasdaq:amtx) with a buy recommendation.

Fri Apr 28, 2023

Rating

aemetis secures $34m contract to supply biodiesel from its kakinada plant to indian omcs.

Mon Apr 17, 2023

Activity

aemetis secures $34m in biodiesel contracts from india oil refiners. ) universal biofuels subsidiary in india has secured contracts from the three government-controlled oil marketing companies (omc'.s) to supply ~

Mon Apr 17, 2023

Activity

: aemetis stock price target cut to $10 from $18 at stifel nicolaus. this is a real-time headline. these are breaking news delivered the minute it happens delivered ticker-tape style. visit www.marketwatch.com or the e page for more information about this

Fri Apr 14, 2023

Potential

: aemetis stock price target cut to $2.50 from $4.25 at ubs. this is a real-time headline. these are breaking news delivered the minute it happens delivered ticker-tape style. visit www.marketwatch.com or the e page for more information about this breakin

Thu Apr 13, 2023

Potential

 
 
 
StocksRunner

Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future

FIND US ON

StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our daily AMTX alerts

Enter your email to receive daily alerts

 
Home

Leading Gainers

Upgrades

Downgrades

Top Leaders

 
Categories

Ipo's

Dividend

Option Activity

Insiders Activity

Institutional Holdings

 
Tags

New Products

FDA Approvals

Agreements

Financial Reports

 
About Us

Log In

Sign Up

Contact Us

Terms of use

Privacy Policy

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
StocksRunner

StocksRunner

Get the pulse of the market

 
StocksRunner

AMTX Aemetis

Last Price
6.63
Change
+10.13%
 

Summary

  Login to display Aemetis (AMTX) recommendation from the last 90 days from financial news and social media.

 
 
2.06
2.75
4.7
5.53
 
 
1m
3m
6m
1y
 
Sentiment

Strengths

Rewards

 Upgraded on attractively valued

Risk Analysis

Risk Analysis

 Analysts lowered price target

Risk Analysis

 Earnings are forecast to decrease

Technical Indicators

Technical Indicators

 Up While Market is Down

Technical Indicators

 RSI is overbought

 
 
 
 
Street Consensus
 
Buy
Opinion
Trend
Score
Potential
Score
 
100%
0%
0%
On Track
On Track
On Track
 
54%
38%
Positive
Negative
7 out of 13
events present
5 out of 13
events present
 

Street Opinion

Street view is bullish but have mixed views on the near-term outlook

 
 
Analysts Opinion
Hover the category for more information
 
 

Earnings

×
 

Earnings

2.00
 

StocksRunner

 Reported a weak earnings

 
 

Rating

×
 

Rating

5.00
 

StocksRunner

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

3.00
 
 

Activity

×
 

Activity

3.71
 
 

Future

×
 

Future

1.00
 

StocksRunner

 Analysts lowered price target

StocksRunner

 Earnings are forecast to decrease

 
 

Analysts Opinion

Analysts opinion is negative but has improved from the past 3 months

 
 
 
 
 
Events Rating
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
 
Risk Level
 
StocksRunner
 

Aemetis (AMTX) has High Risk Level.  Click here to check what is your level of risk

 
 
 

Events Calendar

Hover for information

 
May
 
S
M
T
W
T
F
S
 
June
 
S
M
T
W
T
F
S
 
 
 
 
Highlights
Last
Modify
Closing
Price
%
Change

 
Investors Selling
This Week
5.78
-16.83%
 
Weak Earnings
2 Month Ago
1.75
-19.35%
 
Buy Rating
2 Month Ago
2.22
+2.55%
 
Price Target Lowered
2 Month Ago
2.23
+3.24%
 
 
 
StocksRunner

Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future

FIND US ON

StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our daily AMTX Alerts

Enter your email to receive daily alerts

 
Home

Leading Gainers

Upgrades

Downgrades

Top Leaders

Categories

Ipo's

Dividend

Option Activity

Insiders Activity

Institutional Holdings

Tags

New Products

FDA Approvals

Agreements

Financial Reports

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
 
 
 

Top Headlines